Stock Research for SPEX

SPEX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SPEX Stock Chart & Research Data

The SPEX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SPEX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SPEX Due diligence Resources & Stock Charts

The SPEX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SPEX Detailed Price Forecast - CNN Money CNN View SPEX Detailed Summary - Google Finance
Yahoo View SPEX Detailed Summary - Yahoo! Finance Zacks View SPEX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SPEX Trends & Analysis - Trade-Ideas Barrons View SPEX Major Holders - Barrons
NASDAQ View SPEX Call Transcripts - NASDAQ Seeking View SPEX Breaking News & Analysis - Seeking Alpha
Spotlight View SPEX Annual Report - CompanySpotlight.com OTC Report View SPEX OTC Short Report - OTCShortReport.com
TradeKing View SPEX Fundamentals - TradeKing Charts View SPEX SEC Filings - Bar Chart
WSJ View Historical Prices for SPEX - The WSJ Morningstar View Performance/Total Return for SPEX - Morningstar
MarketWatch View the Analyst Estimates for SPEX - MarketWatch CNBC View the Earnings History for SPEX - CNBC
StockMarketWatch View the SPEX Earnings - StockMarketWatch MacroAxis View SPEX Buy or Sell Recommendations - MacroAxis
Bullish View the SPEX Bullish Patterns - American Bulls Short Pains View SPEX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SPEX Stock Mentions - StockTwits PennyStocks View SPEX Stock Mentions - PennyStockTweets
Twitter View SPEX Stock Mentions - Twitter Invest Hub View SPEX Investment Forum News - Investor Hub
Yahoo View SPEX Stock Mentions - Yahoo! Message Board Seeking Alpha View SPEX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SPEX - SECform4.com Insider Cow View Insider Transactions for SPEX - Insider Cow
CNBC View SPEX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SPEX - OTC Markets
Yahoo View Insider Transactions for SPEX - Yahoo! Finance NASDAQ View Institutional Holdings for SPEX - NASDAQ


Stock Charts

FinViz View SPEX Stock Insight & Charts - FinViz.com StockCharts View SPEX Investment Charts - StockCharts.com
BarChart View SPEX Stock Overview & Charts - BarChart Trading View View SPEX User Generated Charts - Trading View




Latest Financial News for SPEX


Spherix Announces Preclinical Pancreatic Cancer Treatment Study Moving Forward
Posted on Tuesday November 27, 2018

NEW YORK, Nov. 27, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) today announced the funding of a study for KPC34, for pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDA).  PDA is considered the deadliest of major cancers and patients are in desperate need of improved therapies. PDA is caused by chronic inflammatory stress associated with the increasingly common afflictions of obesity, type 2 diabetes, and pancreatitis, exacerbated by smoking and drinking.  KPC34 is a candidate therapeutic because it is activated preferentially inside tumor cells to release an inhibitor of DNA replication and a separate tumor promotion inhibitor. Annually, more than 350,000 new cases of pancreatic cancer are diagnosed across the world.  According to the American Society of Clinical Oncology, a six-month course of gemcitabine, the chemotherapy drug typically used to treat advanced pancreatic cancer, costs about $23,500.


Today's Research Reports on Trending Tickers: Twilio and Spherix
Posted on Tuesday November 27, 2018

NEW YORK, NY / ACCESSWIRE / November 27, 2018 / Twilio shares were on the rise on an “outperform” rating reiterated from an Oppenheimer analyst last week while Spherix Incorporated shares popped on news ...


Spherix Announces Ownership Interest in Electric Scooter Business
Posted on Monday November 26, 2018

From renting out an unused road bike, to running a fleet of hundreds of electric scooters, Mellow provides a flexible entry for anyone interested in the growing shared vehicles space. Additional information about the investment will be available in the Form 8-K, filed by Spherix with the Securities and Exchange Commission.


Spherix Announces the Addition of Dr. Rana Quraishi to Company's Advisory Board
Posted on Monday October 29, 2018

NEW YORK, Oct. 29, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX) today announced that it has added Dr. Rana Quraishi to the Company's Advisory Board to assist the Company in evaluating potential opportunities in the biopharmaceutical area. Dr. Rana Quraishi is the Director of New Ventures, at UM Ventures University of Maryland, Baltimore.  UM Ventures is a joint initiative bringing the University of Maryland, Baltimore and University of Maryland, College Park together to commercialize discoveries and create economic impact by engaging partners in industry and social ventures.  Dr. Quraishi has a Ph.D. in Molecular Biology and Biochemistry from Columbia University where she was also an undergraduate and an M.S. from Harvard University.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.